Handgrip strength-based cachexia index with frailty in cancer survivors: Evidence from health and retirement study [0.03%]
基于手握力的恶病质指数在癌症幸存者中的应用：来自健康与退休研究的证据
Fan Zhang,Xinyue Yang,Yan Bai et al.
Fan Zhang et al.
Geriatric assessment practices in oncology: A survey of Australian clinicians [0.03%]
澳大利亚肿瘤学临床医生的姑息治疗实践调查
Antonina Obayo,Francine Antoinette Ocampo,Baldwin Lau et al.
Antonina Obayo et al.
Brentuximab vedotin and dose attenuated chemoimmunotherapy for patients 75 years and older with diffuse large B-cell lymphoma with analysis of outcomes by frailty [0.03%]
Brentuximab Vedotin及减量化疗免疫治疗治疗弥漫大 B 细胞淋巴瘤老年患者（≥75 岁）及其虚弱结局分析
Patrick M Reagan,Allison Magnuson,Craig A Portell et al.
Patrick M Reagan et al.
Introduction: Dose attenuated rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-miniCHOP) is a curative-intent regimen that balances safety and efficacy in older patients with diffuse large B-cell l...
Less treatment, but whose choice? Geriatric considerations in breast cancer care [0.03%]
少治疗，但自主选择吗？——乳腺癌患者老年综合评估专家共识
Mohammad Shkokani,Louis John Koizia,Benjamin Howell Lole Harris
Mohammad Shkokani
Letter to the editor: Cardiovascular and cancer-specific mortality in older patients with advanced non-small cell lung cancer following the introduction of immuno-oncology therapies [0.03%]
致编辑的信：免疫-肿瘤学疗法的应用对老年晚期非小细胞肺癌患者的心血管和癌症特异性死亡率的影响
Sari Luthfiyah,Ach Arfan Adinata,Joylyn L Mejilla et al.
Sari Luthfiyah et al.
Barriers and facilitators of deprescribing for older adults with cancer and polypharmacy [0.03%]
老年人癌症多药治疗减药的障碍与促进因素
Kofi Gyasi Agyei,Arul Malhotra,Sally A Norton et al.
Kofi Gyasi Agyei et al.
Introduction: Polypharmacy affects up to 93% of older adults with cancer and increases risks of treatment toxicity, drug interactions, and adverse outcomes. Deprescribing, the planned discontinuation of potentially inappr...
Comment on "Effect of geriatric co-management on independence, quality of life, and severe toxicity in vulnerable older patients with cancer: Results of a randomized clinical trial" [0.03%]
关于老年共管对脆弱老年癌症患者独立性、生活质量及严重毒性影响的评论：一项随机临床试验的结果
Daniel Sibley,Adeline Gonzales,Martine Puts
Daniel Sibley